# 3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation

> **NCT02444429** · PHASE3 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 346 (actual)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** Corticosteroid boluses Methylprednisolone
- **OTHER:** No therapeutic modification
- **OTHER:** Stop maintenance corticotherapy

## Key facts

- **NCT ID:** NCT02444429
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-02
- **Primary completion:** 2024-06-21
- **Final completion:** 2024-06-21
- **Target enrollment:** 346 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02444429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02444429, "3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02444429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*